Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
Condition: Anaemia Interventions: Drug: Daprodustat tablets; Drug: Matching placebo tablets; Drug: Epoetin alfa vials; Drug: Saline vials or bags Sponsor: GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials